drugset / Trial / NCT02986529

A Study to Assess the Bioavailability of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Male Subjects

NCT02986529

Phase 1 Completed 15 enrolled Shanghai Greenvalley Pharmaceutical Co., Ltd.
RandomizedCrossoverQuadruple-blindBasic science

Summary

To evaluate the Bioavailability for GV-971 capsules of 150 mg, 300mg, and 450mg after administration of single oral doses of 900mg in healthy Male subjects.

Timeline

Start
2016-11
Primary completion
2017-02-24
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Subject GV-971 Other / unclassified 900 mg Oral

Indications

No indication recorded.